Opioid peptide pharmacology and immunocytochemistry in an animal model of self-sustaining status epilepticus
- 1 March 1999
- journal article
- Published by Elsevier in Neuroscience
- Vol. 89 (1) , 167-173
- https://doi.org/10.1016/s0306-4522(98)00320-0
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Changes in Hippocampal Circuitry after Pilocarpine-Induced Seizures as Revealed by Opioid Receptor Distribution and ActivationJournal of Neuroscience, 1997
- Opioid peptides content in the rat brain during the ictal phase and after pentylenetetrazol-kindled ratsComparative Biochemistry and Physiology Part A: Physiology, 1995
- Opioid peptide expression in models of chronic temporal lobe epilepsyNeuroscience, 1995
- Dynorphin opioids present in dentate granule cells may function as retrograde inhibitory neurotransmittersJournal of Neuroscience, 1994
- Antagonism of kainic acid lesions in the mouse hippocampus by U-54494A and U-50488HLife Sciences, 1992
- A study on opioid peptides in CSF of patients with epilepsyEpilepsy Research, 1990
- Seizures induce dramatic and distinctly different changes in enkephalin, dynorphin, and CCK immunoreactivities in mouse hippocampal mossy fibersJournal of Neuroscience, 1988
- Kainic acid as a tool to study the regulation and function of opioid peptides in the hippocampusToxicology, 1987
- Intranigral dynorphin-1-13 suppresses kindled seizures by a naloxone-insensitive mechanismBrain Research, 1987
- Effects of selective μ- and δ-opioid peptides on kindled amygdaloid seizures in ratsNeuroscience Letters, 1987